Antibody inhibitors of gdf-8 and uses thereof
CA 2469230 C · Owner: Davies, Monique V. · Inventors: Davies, Monique V.; Aghajanian, Jane (Deceased); O'Hara, Denise
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The disclosure provides novel antibodies against growth and differentiation factor-8 (GDF-8), including antibody fragments which inhibit GDF-8 activity , in vitro and in vivo. The disclosure also provides methods for diagnosing preventing, or treating degenerative disorders of muscle bone, or insulin , metabolism.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 2002 and granted February 21, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.